Stockscreener 앱 받기
8.19
7.04%
-0.62
시장 영업 전:
8.17
-0.02
-0.24%
전일 마감가:
$8.81
열려 있는:
$8.85
하루 거래량:
3.43M
Relative Volume:
1.43
시가총액:
$1.06B
수익:
$628.25M
순이익/손실:
$-78.55M
주가수익비율:
-13.21
EPS:
-0.62
순현금흐름:
$-29.73M
1주 성능:
+15.68%
1개월 성능:
+58.72%
6개월 성능:
-14.51%
1년 성능:
-48.39%
1일 변동 폭
$8.165
$8.85
1주일 범위
$6.945
$9.06
52주 변동 폭
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
명칭
Neogenomics Inc
전화
(239) 768-0600
주소
9490 NEOGENOMICS WAY, FORT MYERS, FL
NEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
8.19 | 1.14B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
484.55 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.44 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
633.95 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.22 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
184.62 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-29 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 개시 | Guggenheim | Neutral |
| 2025-04-30 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 개시 | Jefferies | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-08-21 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-02-24 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-02-01 | 업그레이드 | Needham | Hold → Buy |
| 2022-08-26 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-22 | 다운그레이드 | Needham | Buy → Hold |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-03-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-29 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 재개 | Stephens | Overweight |
| 2021-12-16 | 개시 | Cowen | Outperform |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-25 | 재개 | Needham | Buy |
| 2021-02-25 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-12-11 | 재개 | BTIG Research | Buy |
| 2020-10-28 | 재확인 | Needham | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-08-28 | 개시 | Guggenheim | Buy |
| 2020-07-29 | 재확인 | Needham | Buy |
| 2020-06-25 | 개시 | BofA/Merrill | Buy |
| 2020-04-21 | 재개 | Stephens | Overweight |
| 2020-03-02 | 재개 | Craig Hallum | Buy |
| 2020-02-28 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-01 | 재확인 | Needham | Buy |
| 2019-03-29 | 재확인 | Needham | Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-10-24 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 개시 | Leerink Partners | Outperform |
| 2018-05-02 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-08-24 | 개시 | Gabelli & Co | Buy |
| 2016-12-15 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Neogenomics Inc 주식(NEO)의 최신 뉴스
NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt - 富途牛牛
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is now a turning point for NeoGenomics Inc.July 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - PR Newswire
What are NeoGenomics Inc.’s recent SEC filings showingExit Point & Technical Pattern Alert System - khodrobank.com
Applying big data sentiment scoring on NeoGenomics Inc.Analyst Downgrade & Risk Managed Investment Signals - Newser
Real time social sentiment graph for NeoGenomics Inc.Weekly Profit Report & High Return Trade Guides - Newser
Has NeoGenomics Inc. found a price floorQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser
What data driven models say about NeoGenomics Inc.’s futureMarket Trend Review & Safe Swing Trade Setup Alerts - Newser
Should I trade or invest in NeoGenomics Inc.Market Trend Summary & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Ranking NeoGenomics Inc. among high performing stocks via toolsGap Down & Free Long-Term Investment Growth Plans - Newser
Using Python tools to backtest NeoGenomics Inc. strategiesQuarterly Trade Report & Precise Trade Entry Recommendations - Newser
What’s next for NeoGenomics Inc. stock priceGDP Growth & Pattern Based Trade Signal System - Newser
When is the best time to exit NeoGenomics Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Signal strength of NeoGenomics Inc. stock in tech scannersJuly 2025 Closing Moves & Verified Momentum Stock Ideas - Newser
Is NeoGenomics Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Can momentum traders help lift NeoGenomics Inc.Earnings Recap Summary & Fast Entry Momentum Trade Alerts - Newser
Does NeoGenomics Inc. qualify in momentum factor screeningPrice Action & Precise Trade Entry Recommendations - Newser
Chart based analysis of NeoGenomics Inc. trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser
Does NeoGenomics Inc. have a sustainable dividendTrade Analysis Report & Risk Managed Investment Strategies - khodrobank.com
Applying sector rotation models to NeoGenomics Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
What is NeoGenomics Inc. s debt to equity ratioJuly 2025 PostEarnings & High Win Rate Trade Tips - khodrobank.com
Is now a turning point for NeoGenomics IncIndex Update & Technical Pattern Based Buy Signals - Newser
NeoGenomics reports Q2 revenue of $181.3mln, net loss of $45.1mln. - AInvest
Fort Myers cancer lab firm wins federal patent lawsuit - Business Observer
Neogenomics stock price target raised to $11 from $6.50 at Stephens - Investing.com Canada
Neogenomics shares fall 1.25% premarket after court rules in favor of patent invalidity. - AInvest
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN
Does NeoGenomics Inc. meet Warren Buffett’s criteriaTrade Risk Summary & Daily Oversold Stock Bounce Ideas - khodrobank.com
Will NeoGenomics Inc. outperform the market in YEARVolume Spike & Daily Chart Pattern Signals - khodrobank.com
Why is NeoGenomics Inc. stock going upCPI Data & Fast Entry Momentum Trade Alerts - khodrobank.com
Technical Charts Suggest Momentum Shift in CCRN getLinesFromResByArray error: size == 0 - kangso.co.kr
Full technical analysis of NeoGenomics Inc. stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
NeoGenomics rallies after court win in Natera patent dispute - MSN
Applying big data sentiment scoring on NeoGenomics IncWeekly Trade Recap & High Conviction Investment Ideas - Newser
Neogenomics Soars 21.64% on Legal Victory, Cancer Diagnostics Dominance - AInvest
Is a relief rally coming for NeoGenomics Inc. holdersJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Can NeoGenomics Inc. deliver consistent EPS growthMarket Performance Recap & Long-Term Safe Investment Plans - khodrobank.com
How to interpret RSI for NeoGenomics Inc. stockMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Can NeoGenomics Inc. rally from current levelsEarnings Growth Report & Safe Entry Zone Identification - Newser
Has NeoGenomics Inc. formed a bullish divergenceGap Down & Weekly Setup with High ROI Potential - Newser
Automated trading signals detected on NeoGenomics Inc.July 2025 Trends & Consistent Profit Trade Alerts - Newser
Analysts Backtest Strategies on NeoGenomics Inc. With Promising Results getLinesFromResByArray error: size == 0 - 더경남뉴스
NeoGenomics Sees Price Target Reduced Amidst Steady Optimism - StocksToTrade
NeoGenomics Inc. stock outlook for YEARPortfolio Profit Report & Fast Gain Swing Alerts - Newser
Can swing trading help recover from NeoGenomics Inc. lossesTrade Exit Summary & Low Risk High Win Rate Picks - Newser
Neogenomics Inc (NEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.17%
0.45%
자본화:
|
볼륨(24시간):